TMEM201 is an inner nuclear membrane (INM) protein encoded by the TMEM201 gene (Gene ID: 199953) in humans. Key features include:
Structure: Contains an N-terminal domain with conserved CxxC motifs for zinc finger formation and a nucleocytoplasmic C-terminal domain .
Function:
Endothelial Cell Behavior:
LINC Complex Interaction:
Cancer Metastasis:
Recombinant TMEM201 is utilized to:
Develop inhibitors targeting TMEM201-LINC interactions for cancer therapy .
Study angiogenesis defects in in vitro models (e.g., EC sprouting assays) .
TMEM201 is an inner nuclear membrane (INM) protein that forms part of the nuclear envelope complex. The nuclear envelope comprises the outer nuclear membrane, inner nuclear membrane, and nucleopore. TMEM201 is specifically localized to the inner nuclear membrane, with its structure featuring five predicted transmembrane segments (TMSs). The protein's topology includes both N-terminus and C-terminus (before the last TMS) exposed in the nucleoplasm, which is critical for its functional interactions .
TMEM201 plays a crucial role in regulating endothelial cell migration and controlling the process of angiogenesis. Research has demonstrated that TMEM201 positively modulates the invasion and migration of cells, with its depletion resulting in impaired migration capabilities. Additionally, TMEM201 participates in establishing endothelial cell polarity during directional migration. Mechanistically, TMEM201 interacts with the linker of nucleoskeleton and cytoskeleton (LINC) complex, which is essential for coordinated cell movement .
TMEM201 is a positive regulator of angiogenesis, the process of new blood vessel formation. When TMEM201 expression is depleted in human umbilical vein endothelial cells (HUVECs), their angiogenic behavior is significantly impeded, with reduced tube formation capacity (>50% fewer junctions and branches compared to control groups). Additionally, TMEM201 knockdown results in decreased number and length of endothelial cell sprouts in fibrin gel bead sprouting assays. Competitive sprouting assays further confirm that TMEM201 expression positively correlates with endothelial cell sprouting ability .
For studying TMEM201 function in vitro, human umbilical vein endothelial cells (HUVECs) and the endothelial cell line EA.hy926 have proven to be effective models. These cell types allow for various functional assays, including:
Tube formation assays to assess angiogenic behavior
Fibrin gel bead sprouting assays to evaluate sprouting angiogenesis
Transwell migration assays to quantify cell migration
Wound healing assays to study directional migration
Additionally, competitive sprouting assays using differentially labeled cells (expressing control or TMEM201-knockdown constructs) provide a powerful approach to directly compare the effects of TMEM201 depletion within the same experimental environment .
Two primary in vivo models have been validated for studying TMEM201 function:
Tmem201-knockout mice: These models show arrested retinal vessel development and defective aortic ring sprouting, confirming the protein's role in angiogenesis.
Zebrafish models: Loss of tmem201 in zebrafish impairs intersegmental vessel development, providing another vertebrate model system to study TMEM201's role in vascular development .
These complementary models allow researchers to verify in vitro findings in physiologically relevant contexts and explore developmental aspects of TMEM201 function.
Short hairpin RNA (shRNA)-mediated gene silencing has been successfully applied to study TMEM201 function. The approach involves:
Design of shRNAs specifically targeting different regions of TMEM201 mRNA
Validation of knockdown efficiency through immunoblotting and RT-qPCR
Functional assays to assess phenotypic changes
Research shows that effective TMEM201 knockdown can be achieved with multiple shRNA constructs (e.g., TMEM201-shRNA-1# and TMEM201-shRNA-2#), reducing the risk of off-target effects by allowing comparison between different constructs .
| shRNA Construct | Target Region | Validation Method | Knockdown Efficiency |
|---|---|---|---|
| TMEM201-shRNA-1# | Region 1 of TMEM201 mRNA | Immunoblotting, RT-qPCR | >50% reduction in expression |
| TMEM201-shRNA-2# | Region 2 of TMEM201 mRNA | Immunoblotting, RT-qPCR | >50% reduction in expression |
TMEM201 directly interacts with components of the linker of nucleoskeleton and cytoskeleton (LINC) complex, which is critical for its function in cell migration. Specific interaction patterns include:
Interaction with SUN1/2: Co-immunoprecipitation (CoIP) assays have confirmed direct interaction between TMEM201 and SUN1/2 proteins, core components of the LINC complex.
Interaction with LaminA/C: TMEM201 also interacts with LaminA/C, a key component of the nuclear lamina.
These interactions have been verified through both immunofluorescence confocal studies and various CoIP assays. The N-terminus of TMEM201, which is exposed in the nucleoplasm, is particularly important for these interactions .
The N-terminal domain of TMEM201 is essential for its function in endothelial cells. This domain:
Interacts directly with the LINC complex components
Is required for regulating endothelial cell migration
Is exposed in the nucleoplasm, facilitating its interactions with nuclear proteins
The predicted topology of TMEM201 includes five transmembrane segments, with both the N-terminus and C-terminus (before the last TMS) exposed in the nucleoplasm. This structural arrangement allows for functional interactions with nuclear components involved in cell migration and angiogenesis .
While the search results don't specifically address recombinant TMEM201 production, based on similar nuclear membrane protein production protocols, researchers can consider:
Expression System Selection: E. coli-based expression systems can be used for producing segments of TMEM201, particularly the soluble N-terminal domain. For full-length protein with proper folding and post-translational modifications, mammalian or insect cell expression systems are recommended.
Purification Approach: For membrane proteins like TMEM201, detergent-based extraction followed by affinity chromatography (using tags such as His or FLAG) is typically effective. Size exclusion chromatography can be used as a final purification step.
Protein Stabilization: Addition of carrier proteins (like BSA) or appropriate detergents can enhance stability of the recombinant protein, similar to approaches used with other recombinant proteins .
Functional validation of recombinant TMEM201 can be performed through several complementary approaches:
Binding Assays: Co-immunoprecipitation or pull-down assays to verify interaction with known binding partners like SUN1/2 and LaminA/C
Cell-Based Rescue Experiments: Introduction of recombinant TMEM201 into TMEM201-knockdown cells to assess rescue of migration and angiogenic phenotypes
Structural Integrity Assessment: Circular dichroism or limited proteolysis to confirm proper folding
Subcellular Localization: Immunofluorescence studies to verify proper targeting to the inner nuclear membrane when introduced into cells
The discovery that TMEM201 regulates endothelial cell migration and angiogenesis has significant implications for various disease models:
Cancer Research: Since TMEM201 positively modulates cell invasion, migration, and angiogenesis (all crucial for tumor development), it may represent a potential target for anti-angiogenic cancer therapies.
Vascular Disorders: The role of TMEM201 in retinal vessel development and aortic ring sprouting suggests its potential involvement in vascular developmental disorders.
Wound Healing: The positive effect of TMEM201 on cell migration and angiogenesis indicates it may play a role in wound healing processes.
Inflammatory Conditions: Given the importance of angiogenesis in inflammatory responses, TMEM201 may be relevant to inflammatory disease models .
When investigating TMEM201 knockdown effects, the following controls are essential:
Scrambled shRNA Control: Use of a non-targeting shRNA with the same vector backbone to account for effects of the delivery method.
Multiple shRNA Constructs: Utilization of at least two different shRNA sequences targeting TMEM201 to distinguish specific effects from off-target effects.
Rescue Experiments: Re-introduction of shRNA-resistant TMEM201 to confirm that observed phenotypes are specifically due to TMEM201 depletion.
Positive Controls: Including known regulators of endothelial cell migration or angiogenesis as positive controls for functional assays.
Fluorescence Tag Controls: When using fluorescently tagged constructs, switching the fluorescent proteins between control and experimental conditions to exclude tag-specific effects, as demonstrated in the competitive sprouting assays .
To differentiate between direct effects on migration and indirect effects on proliferation:
Short-Duration Assays: Use shorter-term assays like wound healing (e.g., 8 hours) to minimize the influence of proliferation differences.
Proliferation Controls: Perform parallel proliferation assays to quantify and account for any differences in cell growth rates.
Cell Cycle Inhibitors: Use of cell cycle inhibitors in migration assays can help isolate migration effects from proliferation effects.
Live Cell Imaging: Track individual cell movements to directly measure migration parameters independent of cell number increases .
When analyzing TMEM201's interaction with the LINC complex, researchers should consider:
Reciprocal Co-IP Experiments: Perform immunoprecipitation in both directions (i.e., pull down TMEM201 and probe for LINC components, and vice versa) to confirm specific interactions.
Negative Controls: Include negative control proteins that are not expected to interact with either TMEM201 or LINC components.
Domain Mapping: Use truncated versions of TMEM201 to map the specific domains involved in the interaction.
Proximity Ligation Assays: Consider using these to visualize and quantify protein-protein interactions in situ.
Detergent Conditions: Carefully optimize detergent conditions for membrane protein extraction to maintain native interactions while effectively solubilizing the proteins .
While current research establishes TMEM201's role in developmental angiogenesis, several promising research directions for pathological angiogenesis include:
Tumor Angiogenesis: Investigating TMEM201 expression levels in tumor vasculature and their correlation with tumor progression and metastasis.
Ischemic Diseases: Examining whether TMEM201 manipulation could enhance therapeutic angiogenesis in models of ischemic heart disease or stroke.
Retinopathies: Given TMEM201's role in retinal vessel development, exploring its involvement in diabetic retinopathy or age-related macular degeneration.
Inflammatory Angiogenesis: Studying TMEM201's potential role in inflammatory conditions with aberrant angiogenesis, such as rheumatoid arthritis or psoriasis .
While the search results don't directly address post-translational modifications of TMEM201, this represents an important area for future research:
Phosphorylation: Investigating whether TMEM201 is phosphorylated in response to angiogenic signals and how this might regulate its interactions with the LINC complex.
Ubiquitination: Studying if TMEM201 stability and turnover are regulated by the ubiquitin-proteasome system.
Glycosylation: Examining potential glycosylation sites and their impact on TMEM201 localization and function.
SUMOylation: Exploring whether TMEM201, like other nuclear proteins, undergoes SUMOylation that affects its nuclear interactions .
Several high-throughput approaches could significantly advance TMEM201 research:
Interactome Analysis: Mass spectrometry-based proteomics to comprehensively identify TMEM201 binding partners under various conditions.
CRISPR Screens: Genome-wide CRISPR screens to identify genes that synthetically interact with TMEM201 or modify phenotypes associated with TMEM201 manipulation.
Transcriptomics: RNA-seq analysis of TMEM201-deficient cells to identify downstream pathways affected by TMEM201 loss.
Small Molecule Screens: High-throughput screening to identify compounds that modulate TMEM201 expression or function, potentially yielding tools for further research or therapeutic development.
Single-cell Analysis: Single-cell approaches to understand the heterogeneity of TMEM201 expression and function in complex tissues like tumor vasculature .